Platinum nanoparticles inhibit intracellular ROS generation and protect against cold atmospheric plasma-induced cytotoxicity

Sebnem Gunes, Zhonglei He, David van Acken, Renee Malone, Patrick J. Cullen, James F. Curtin

Research output: Contribution to journalArticlepeer-review

Abstract

Platinum nanoparticles (PtNPs) have been investigated for their antioxidant abilities in a range of biological and other applications. The ability to reduce off-target cold atmospheric plasma (CAP) cytotoxicity would be useful in Plasma Medicine; however, little has been published to date about the ability of PtNPs to reduce or inhibit the effects of CAP. Here we investigate whether PtNPs can protect against CAP-induced cytotoxicity in cancerous and non-cancerous cell lines. PtNPs were shown to dramatically reduce intracellular reactive species (RONS) production in U-251 MG cells. However, RONS generation was unaffected by PtNPs in medium without cells. PtNPs protect against CAP induced mitochondrial membrane depolarization, but not cell membrane permeabilization which is a CAP-induced RONS-independent event. PtNPs act as potent intracellular scavengers of reactive species and can protect against CAP induced cytotoxicity. PtNPs, showing no significant biocorrosion, may be useful as a catalytic antioxidant for healthy tissue and for protecting against CAP-induced tissue damage.

Original languageEnglish
Article number102436
Number of pages11
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume36
DOIs
Publication statusPublished - Aug 2021

Keywords

  • Antioxidants
  • Cancer treatment
  • Cold atmospheric plasma
  • Free radicals
  • Platinum nanoparticles

Fingerprint

Dive into the research topics of 'Platinum nanoparticles inhibit intracellular ROS generation and protect against cold atmospheric plasma-induced cytotoxicity'. Together they form a unique fingerprint.

Cite this